Drug name - Zetia
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7612058 | ORGANON | Methods for inhibiting sterol absorption |
Oct, 2025
(3 years from now) | |
|
US7612058
(Pediatric) | ORGANON | Methods for inhibiting sterol absorption |
Apr, 2026
(3 years from now) | |
Drugs and Companies using EZETIMIBE ingredient
Treatment: To reduce elevated total-c, ldl-c, apo b and non-hdl-c in patients with primary hyperlipidemia by administration of ezetimibe alone or in combination with a statin or with fenofibrate; reduction of elevated plasma sterol and/or stanol levels in a mammal
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 10MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.